Gene Bridges licenses Red/ET Recombineering to Genencor

02-Apr-2008

Gene Bridges GmbH announced that Genencor International Inc. USA, a part of Danisco US Inc., has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges.

Under the terms of the agreement, Gene Bridges has licensed the Red/ET technology to Genencor for the purpose of genetically engineering recombinant micro-organisms for use in industrial applications. No financial details were disclosed.

Gary Stevens, CEO of Gene Bridges GmbH, commented: "We are very pleased to add Danisco to the list of major industrial biotechnology companies using Red/ET. Recombineering is the technology of choice in DNA engineering and is used worldwide in industry and academia."

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance